References
- Cole LA. hCG, the wonder of today's science. Reprod Biol Endocrinol 2012;10:24–42
- Choi J. Smitz Johan. Luteinizing hormone and human chorionic gonadotropin: origins of difference. Mol Cell Endocrinol 2014;384:203–13
- Zavadil M, Feyereisl J, Safar P, et al. Syndrome of persistent low levels of chorionic gonadotropin (hCG). Ceska Gynekol 2006;71:136–42
- Laurence AC. Phantom hCG and phantom choriocarcinoma. Gynecol Oncol 1998;71:325–9
- Rotmensch S, Cole LA. False diagnosis and needless therapy of presumed malignant disease in women with false-positive human chorionic gonadotropin concentrations. Lancet 2000;355:712–15
- Cole LA, Khanlian SA. Easy fix for clinical laboratories for the false positive defect with the Abbott AxSym total ß-hCG test. Clin Biochem 2004;37:344–9
- Esfandiari N, Goldberg JM. Heterophile antibody blocking agent to confirm false positive serum human chorionic gonadotropin assay. Obstet Gynecol 2003;101:1144–6
- De Backer B, Goffin F, Nisolle M, Minon JM. Persistent low hCG levels beyond pregnancy: report of two cases and review of the literature]. Ann Biol Clin (Paris) 2013;71:496–502
- Berglund L, Holmberg NG. Heterophilic antibodies against rabbit serum causing falsely elevated gonadotropin levels. Acta Obstet Gynecol Scand. 1989;68:377–8
- Vladutiu AO, Sulewski JM, Pudlak KA, Stull CG. Heterophilic antibodies interfering with radioimmunoassay. A false-positive pregnancy test. JAMA 1982;248:2489–90
- Sasaki S, Sasaki Y, Iino KJ. Recurrent gestational trophoblastic disease in a case of suspected quiescent gestational trophoblastic disease: a case report. Reprod Med 2010;55:317–20
- Seror J, Chabbert-Buffet N, Millot F, et al. False-positive immunometric assay results in the detection of phantom human chorionic gonadotropin: a situation with possible severe iatrogenic consequences. Eur J Obstet Gynecol Reprod Biol 2009;147:239–40
- Rojas-Espaillat L, Houck KL, Hernandez E, Berkowitz RS. Fertility-sparing surgery for persistent gestational trophoblastic neoplasia in the myometrium: a case report. J Reprod Med 2007;52:431–4
- Kohorn EI. Persistent low-level “real” human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma. Gynecol Oncol 2002;85:315–20
- Rzasa PJ, Caride VJ, Prokop EK. Discordant inter-kit results in the radioimmunoassay for choriogonadotropin in serum. Clin Chem 1984;30:1240–3
- Valdes Socin H, Syrios P, Gadisseur R, et al. Persistent low levels of hCG: please do not miss phantom hCG! (pseudohypergonadotropinemia syndrome). Acta Clinica Belgica (abstract) 2013;68:465
- Olsen TG, Hubert PR, Nycum LR. Falsely elevated human chorionic gonadotropin leading to unnecessary therapy. Obstet Gynecol. 2001;98:843–5
- Glenn D, Braunstein MD. False-positive serum human chorionic gonadotropin results: Causes, characteristics, and recognition. Am J Obstet Gynecol 2002;187:217–24
- Cole LA. hCG, five independent molecules. Clin Chim Acta 2012;413:48–65
- American College of Obstetricians and Gynecologists. Avoiding inappropriate clinical decisions based on false-positive human chorionic gonadotropin test results. Obstet Gynecol 2002;100:1057–9
- Boscato LM, Stuart MC. Heterophilic antibodies: a problem for all immunoassays. Clin Chem 1988;34:27–33
- Von Ahsen N, Oellerich M, Schütz E. Use of heterophilic antibody blocking agent (HBT) in reducing false-positive hCG results. Clin Chem 2001;7:1332–3
- Ernest I., Kohorn. Persistent low level “real” human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma. Gynecol Oncol 2002;85:315–20
- Van Cromvoirt SM, Thomas CM, Quinn MA, et al. Identification of patients with persistent trophoblastic disease after complete hydatidiform mole by using a normal 24-hour urine hCG regression curve. Gynecol Oncol 2014;133:542–5